Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
32
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
28%
ALSO IN WDNA
WDNA
90
HOLDINGS
38%
ALSO IN XBI
SECTOR DRIFT (XBI minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 2.3% | 2.4% | 2.3% |
|
NATERA INC | 2.3% | 3.7% | 2.3% |
|
GILEAD SCIENCES INC | 2.4% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.0% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 2.6% | 1.7% | 1.7% |
XBI Overweight Relative to WDNA
|
INSMED INC | 3.1% |
|
HALOZYME THERAPEUTICS INC | 3.1% |
|
INCYTE CORP | 2.8% |
|
ABBVIE INC | 2.5% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.4% |
|
EXELIXIS INC | 2.1% |
|
MODERNA, INC. | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.9% |
|
BIOGEN IDEC INC | 1.7% |
XBI Underweight Relative to WDNA
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
TWIST BIOSCIENCE CORP. | -2.8% |
|
ELI LILLY & CO | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERICEL CORPORATION | -2.1% |
 |
NOVARTIS AG | -1.7% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
LABCORP HOLDINGS | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |
|
AGIOS PHARMACEUTICALS INC | -1.5% |